Why Compare Mounjaro vs Wegovy Across All Dose Strengths?
Understanding the Key Difference Between Mounjaro and Wegovy Mechanisms
The primary difference between Mounjaro and Wegovy lies in their receptor targeting approach. Mounjaro (tirzepatide) works as a dual agonist, activating both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptors simultaneously. Wegovy (semaglutide) focuses exclusively on GLP-1 receptor activation, mimicking the natural fullness hormone your body produces after eating.
This mechanistic difference between Mounjaro and Wegovy may influence how each medication affects appetite regulation and blood sugar management. Both require the same dose escalation schedule—starting at 0.25mg and increasing every 4 weeks until reaching the 2.4mg maintenance dose. Understanding these distinctions helps patients and prescribers make informed decisions about long-term weight management strategies.
Complete Pricing Breakdown: Difference Between Mounjaro and Wegovy Costs
When comparing the difference between Mounjaro and Wegovy pricing, Wegovy offers competitive value across all dose strengths. Our single Wegovy pens range from £79.99 for the 0.25mg starter dose to £209.99 for the 2.4mg maintenance strength. New customers benefit from code FIRST40 whilst returning patients use DOSE25, both applied automatically at checkout to reach these final prices.
Our Getting Started bundles provide convenient dose progression—the Intro Duo (0.25mg & 0.5mg) costs £169.99, whilst the Progress Trio covering weeks 5-16 is available for £369.99. The Ultimate Stability Trio supplies three months of 2.4mg maintenance doses for £649.99, eliminating the need for monthly reordering once you've reached your target dose.
Clinical Evidence: Difference Between Mounjaro and Wegovy Trial Results
In clinical trials, patients taking Wegovy alongside diet and exercise achieved an average weight loss of approximately 15% at 68 weeks in the STEP 1 trial (Wilding et al., NEJM, 2021). The SELECT cardiovascular outcomes trial demonstrated a 20% reduction in major cardiovascular events compared to placebo.
Mounjaro's SURMOUNT trials showed different results due to varying trial designs and patient populations, making direct percentage comparisons inappropriate. Both medications require prescription-only access and must be used alongside a reduced-calorie diet and increased physical activity for optimal effectiveness.
How Wegovy Works: GLP-1 Receptor Mechanism Explained
Wegovy functions as a GLP-1 receptor agonist, mimicking the action of glucagon-like peptide-1, a hormone naturally released by your intestines after eating. This mechanism reduces appetite by acting on brain centres responsible for hunger regulation, whilst simultaneously slowing gastric emptying to promote sustained feelings of fullness. The once-weekly injection delivered via Novo Nordisk's FlexTouch pen provides consistent medication levels throughout the week. Patients typically notice reduced food cravings and smaller portion satisfaction within the first few weeks of treatment. The dose escalation from 0.25mg to 2.4mg allows gradual adjustment whilst minimising potential side effects commonly experienced during treatment initiation.
Streamlined Ordering Process for All Wegovy Doses
Accessing any Wegovy dose through EverydayMeds begins with our comprehensive 3-minute online clinical assessment, designed to evaluate your suitability for this prescription-only medicine. Our qualified prescribers review applications within 3 working days (or 24 hours with express service), ensuring thorough evaluation of medical history and current medications. Once approved, all orders receive next-day delivery via our temperature-controlled cold-chain system, maintaining the 2-8°C storage requirements throughout transit. Our GPhC-registered pharmacy (#9012878) maintains continuous stock levels across all five dose strengths, eliminating treatment interruptions due to supply issues. Customer support remains available throughout your dose escalation journey, providing guidance on injection technique, storage requirements, and progression scheduling.
Storage and Practical Considerations: Difference Between Mounjaro and Wegovy
A significant practical difference between Mounjaro and Wegovy involves storage flexibility once removed from refrigeration. Wegovy pens maintain stability for up to 6 weeks at room temperature below 30°C, compared to Mounjaro's 21-day limit, making Wegovy more suitable for extended travel or lifestyle flexibility. Both medications require initial refrigerated storage at 2-8°C before first use, delivered in insulated packaging to maintain temperature integrity. The FlexTouch pen design provides easy dose administration with clear dosage windows and automatic needle insertion, suitable for patients new to injectable medications. Dose escalation follows the same 4-weekly schedule for both treatments: 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), and 2.4mg maintenance from week 17 onwards. Proper disposal of used pens through pharmacy take-back schemes ensures environmental responsibility and compliance with medication waste regulations.
Complete Dose Journey: Why All Strengths Matter for Mounjaro vs Wegovy Choice
The difference between Mounjaro and Wegovy becomes most apparent during the complete 16+ week dose escalation journey, where having assured access to every strength prevents treatment disruptions. Many patients experience varying tolerance levels at different doses, making the availability of consistency bundles (same dose ×2 pens) crucial for those requiring extended time at particular strengths. Our Gentle Start Trio provides additional 0.25mg support for patients experiencing initial adjustment challenges, whilst the Elevate Trio covers the critical transition period from 1mg through to maintenance dosing.
Long-term treatment success often depends on seamless dose progression without pharmacy switches or stock shortages. EverydayMeds' comprehensive inventory management ensures patients beginning their weight management journey with either medication can continue with the same trusted provider throughout their entire treatment timeline. This continuity proves especially valuable for patients requiring dose adjustments, temporary reductions, or extended maintenance periods at sub-maximum doses based on individual response and tolerability.
Expert Guidance: Making Your Choice Between Mounjaro and Wegovy
Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which option best suits your individual medical profile and lifestyle requirements. Our clinical assessment evaluates factors including previous medication responses, concurrent health conditions, and personal preferences regarding injection frequency and storage convenience. The decision between these prescription-only medicines should consider the complete treatment journey, from initial tolerance through to long-term maintenance strategies. With express consultation options available and comprehensive dose availability, patients can begin their chosen treatment confidently, knowing continued supply and clinical support remain consistently accessible. Contact our clinical team to discuss how the difference between Mounjaro and Wegovy applies to your specific weight management goals and start your assessment today.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
